Michael Douglass

Growth could be incoming.

And it’s not just a tax raise.

Chances are good you'll be one of them. Here's how to think about this big decision.

When the risk outweighs even the best potential growth.

But regardless, it's time to get proactive.

At least in hepatitis C, the answer appears to be yes. But there may be more to the story.

Why trade off between dividends and growth when you can get both?

There are some warning signs. But I still think the stock could be a great long-term pick.

Looking to have more money in retirement? Read on.

There was some good news, if you looked for it.

Fortunately, there's still time.

7x earnings? Seriously?

A lot less than $100,000.

And, surprisingly, it's not about saving extra money.

Slow-growing, solid dividend stocks are a great addition to any investment portfolio. Defensive stocks like Coca-Cola (KO) and Johnson & Johnson (JNJ) do a good job of churning out solid profits in any economy.

They're both big stocks paying solid dividends, but which is the better buy for income investors?

These three stocks are less expensive, better diversified, and have fewer questions surrounding them.

It's probably fewer than you think.

Growth in this healthcare segment could easily support multiple winners, and these big pharma players are likely to be among them.

We don't believe in blindly following billionaires -- but it's always interesting to see where the richest investors are putting their money.